UTI Inc (179900) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of UTI Inc stock KRW 2,031, price KRW 1,830, upside +11.0%, quality 16 out of 100. Rating: fairly valued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
60‑month range 1,784 KRW – 42,050 KRW · fair‑value band 1,516 KRW – 3,032 KRW · the 1,830 KRW price screens below the 2,031 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.
Follow UTI in your weekly email
Every Wednesday you see whether UTI is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
UTI Inc. engages in the research, development, manufacture, and sale of smartphone camera windows and sensor glasses in South Korea and internationally.
Show moreShow less
The company offers cover glass for recognizing fingerprints, glass for IOT, 3D cover glass, flexible display cover glass, G2 TSP and AG glass for car industry; and IOT/ICT composite sensor module, smart haptic module, motor for low-powered drone, and interposer and spacer for semi-conductor industry.
The company was founded in 2010 and is headquartered in Yesan-Eup, South Korea.
Stock analysis
UTI Inc (179900) currently trades at 1,830 KRW, while our model-based Fair Value estimate is 2,031 KRW, so the stock looks roughly fairly valued today (gap 9.9%).
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the data coverage at low.
Scenario range: 1,516 KRW (bear) to 3,032 KRW (bull), the price of 1,830 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 16/100 (below-average quality), in the Technology sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
UTI Inc reported revenue of 20.0B KRW in FY2025 versus 45.2B KRW in FY2021, a compound −18.5%/yr. Reported net income was −37.4B KRW in FY2025.
Key figures
Market cap 35.4B KRW (≈ $26.2M) Micro · P/S ratio 2.20 · EPS (TTM) −936.71 KRW · Net margin −91.7% · Return on equity −30.0% · Return on assets (EBIT) −14.0% (5-year average) · Operating margin −289% · Revenue (TTM) 20.0B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).
What moves the price
The share trades about 94% below its 52-week high and 3% above its 52-week low.
For context, the median of 10 Technology peers we cover trades at −7% fair-value upside, at 11%, 179900 screens cheaper than that median.
Fair Value models
Bear1,516 KRWFair Value 2,031 KRWBull3,032 KRW
Price 1,830 KRW · Upside +11.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−18.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−19.6%
Start year 2020 (pandemic). Over 10 years: +2.7% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.3% (2020) → −241.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 653 stocks
Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score16 · Bottom 25%
Fair Value upside+11.0% · Above median
Profitability
Return on assets−17.5% · Bottom 25%
Net margin (12 months)−91.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−0.5% · Below median
Balance sheet
Debt / equity0.34× · Highest 25%
Valuation Multiplesvs Electronic Components median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "UTI Inc Fair Value". https://www.fairvalue-calculator.com/stock/179900
Frequently asked questions
Is UTI Inc (179900) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 2,031 KRW versus a price of 1,830 KRW, about +11% upside (fairly valued).
What is the fair value of 179900?
Our model-based fair value for UTI Inc is 2,031 KRW (as of Nov 3, 2026), built from audited fundamentals. The current price: 1,830 KRW.
What is the quality score of 179900?
UTI Inc has a Quality Score of 16/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for UTI Inc (179900)?
Our model-based price target is the fair value of 2,031 KRW (as of Nov 3, 2026) from 1 valuation models. Cautious scenario 1,516 KRW, optimistic scenario 3,032 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the UTI Inc stock forecast for 2026?
Our models put fair value at 2,031 KRW, about +11% upside versus a price of 1,830 KRW (fairly valued). Cautious scenario 1,516 KRW, optimistic scenario 3,032 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of UTI Inc (179900)?
UTI Inc reported trailing-twelve-month revenue of about 20.0B KRW (latest available figure, as of Nov 3, 2026).
What is the intrinsic value of UTI Inc (179900)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For UTI Inc it is 2,031 KRW per share (as of Nov 3, 2026), against a price of 1,830 KRW. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is UTI Inc stock overvalued or undervalued in 2026?
As of Nov 3, 2026, 179900 trades below its calculated fair value: price 1,830 KRW, fair value 2,031 KRW, a gap of about +11% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 179900?
No. The price is what the market pays today (1,830 KRW); the fair value is what the company's own numbers justify (2,031 KRW). For UTI Inc the two are 201.37 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is UTI Inc worth?
The market values UTI Inc at about 35.4B KRW (market capitalisation, as of Nov 3, 2026). Per share that is 1,830 KRW; our models calculate a fair value of 2,031 KRW per share.
What do the bullish and bearish scenarios say about 179900?
Our models span a range for UTI Inc: cautious scenario 1,516 KRW, base 2,031 KRW, optimistic 3,032 KRW per share (as of Nov 3, 2026, price 1,830 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of UTI Inc (179900)?
Balance-sheet figures for UTI Inc (as of Nov 3, 2026): return on equity −30.0%, debt of 0.34 per unit of equity. They feed the Quality Score of 16/100, which measures business quality independently of the share price.
How far is 179900 from its 52-week high?
UTI Inc trades at 1,830 KRW, about 94% below its 52-week high of 28,250 KRW and 3% above the low of 1,784 KRW (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 2,031 KRW is for.
Which stocks are comparable to UTI Inc?
From the same area (Technology) we also value Amphenol Corporation, Hon Hai Precision Industry Co, Corning Incorporated, Delta Electronics, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is UTI Inc stock attractive at the current price?
The data as of Nov 3, 2026: price 1,830 KRW, calculated fair value 2,031 KRW (+11%), Quality Score 16/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 179900 calculated?
We run UTI Inc through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of 2,031 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. UTI Inc currently trades 10% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of UTI Inc (179900)?
The closing price on Nov 9, 2026 was 1,830 KRW. Our model-based fair value is 2,031 KRW, about +11% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with UTI Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (1,516 KRW to 3,032 KRW) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of UTI Inc
How large is the market capitalisation of UTI Inc (179900)?
The market capitalisation of UTI Inc is 35.4B KRW (≈ $26.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of UTI Inc (179900)?
The price-to-sales ratio of UTI Inc is 2.20 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of UTI Inc (179900)?
Earnings per share at UTI Inc are −936.71 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of UTI Inc (179900)?
The net margin of UTI Inc is −91.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of UTI Inc (179900)?
The return on equity (ROE) of UTI Inc is −30.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of UTI Inc (179900)?
On an EBIT basis the return on assets of UTI Inc is −14.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of UTI Inc (179900)?
The operating margin of UTI Inc is −289% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at UTI Inc (179900)?
Revenue at UTI Inc is growing −0.5% versus a year earlier (3y avg −18.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at UTI Inc (179900)?
Earnings per share at UTI Inc are growing +41.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does UTI Inc (179900) generate?
The free cash flow of UTI Inc is −110B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does UTI Inc (179900) carry?
The net debt of UTI Inc is 12.2B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch UTI Inc in the live analysis
One click puts UTI Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 3, 2026